Clinical trial Recruiting at 1 site Observational Ages 18 and up

Surgical and antibiotic treatment for pressure ulcers linked to osteomyelitis

Official title: Treatment of Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and Anti-bacterial Agents in Patients Patients With Neuromotor Disability : a Prospective Cohort Study

Run by Institut de Sante Parasport Connecte Synergies · NCT05713149 · Data updated 2026-11-12

This study is testing if a combined surgery and antibiotic treatment can help people with neuromotor disabilities who have pressure ulcers linked to bone infections heal better.

More Osteomyelitis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorInstitut de Sante Parasport Connecte Synergies
Academic / other
Locations1 site (Garches)
StatusRecruiting
StartedFebruary 19, 2023
Main results expectedFebruary 1, 2026
Study endsFebruary 1, 2027
Registry record updatedFebruary 21, 2023
Trial IDNCT05713149 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with neuromotor disabilities requiring treatment for osteomyelitis-associated pressure ulcers.

Probably not a fit

Patients under court protection may not benefit from this study due to eligibility restrictions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients with neuromotor disabilities who are at high risk for osteomyelitis-associated pressure ulcers. It aims to evaluate the effectiveness of a one-stage surgical management approach, which includes bone shaving and flap coverage, followed by tailored antibiotic treatment. Patients will be monitored post-surgery at 30 or 45 days and again at 12 months to assess outcomes and identify factors influencing treatment success or failure. Data will be collected from medical records, covering various clinical and physiological parameters.

Why it matters

Potential benefit: If successful, this approach could improve healing outcomes for patients with complex pressure ulcers and reduce the risk of complications.

How similar studies have gone: While the management of osteomyelitis-associated pressure ulcers is controversial, similar surgical approaches have shown promise in other studies, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients \>= 18 years old ;
* Treated in the Perioperative Disability Unit (UPOH) of the Physical Medicine and Rehabilitation Department of our university hospital;
* Admitted for the treatment of an osteomyelitis-associated pressure ulcer by surgical flap;
* Having a neuromotor disability;
* No opposition to be enrolled in the study from the patient, or from a legally authorized close relative if the patient's state of health does not allow it;
* Affiliation to a social security scheme.

Exclusion Criteria:

* Under court protection.

Where it's running

  • Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP
    Garches, France
    Recruiting

Study contacts

  • Principal investigator: François Genêt, MD-PhD — Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France
  • Study coordinator: François Genêt, MD-PhD
  • Email: françois.genet@aphp.fr
  • Phone: + 33 1 47 10 70 82

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.